NDC 0054-0189 – Buprenorphine and naloxone

Buprenorphine Hydrochloride 8 mg/1; Naloxone Hydrochloride Dihydrate 2 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC0054-0189

Product details

Brand name
Buprenorphine and naloxone
Generic name
Buprenorphine and naloxone
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA203326
Marketed since
June 27, 2014
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine and Naloxone →

Package NDC codes (1)

Package NDCDescriptionSince
0054-0189-1330 TABLET in 1 BOTTLE (0054-0189-13)Jun 27, 2014

Other Buprenorphine and Naloxone products